MO-I-1182

N/A

Report date: 2024/10/22 11:39:59
NME

Base Information

Drug NameMO-I-1182
Drug Alias NameMO-I-1182
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartyl (asparaginyl) β-hydroxylase inhibitors
TargetsAspartyl (asparaginyl) β-hydroxylase
Therapy Area/IndicationsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRhode Island Hospital
China Registration ClassN/A

Develop Information

Active CompaniesRhode Island Hospital
Inactive CompaniesN/A
Active IndicationsCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A